Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Legg Mason was a leading global investment management firm that operated through a multi-affiliate model, providing a wide array of investment strategies across equity, fixed income, and alternative asset classes. Headquartered in Baltimore, Maryland, the company functioned as a parent to several specialized investment centers, including Western Asset, ClearBridge Investments, and Brandywine Global. While not a life sciences company, Legg Mason was a significant institutional investor in the healthcare and biotechnology sectors through its various funds. In July 2020, the company was acquired by Franklin Templeton in a transaction valued at approximately $4.5 billion, creating one of the world's largest independent specialized investment managers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Legg Mason.